Wu Salene M, Brothers Brittany M, Farrar William, Andersen Barbara L
a Department of Psychology , The Ohio State University , Columbus , OH , USA.
J Psychosoc Oncol. 2014;32(6):637-46. doi: 10.1080/07347332.2014.955239.
A substantial number of cancer patients experience depression. This study investigated treatment preferences for depression. Breast cancer survivors (N = 134) completed an anonymous survey asking preference and interest in three treatments for depression: individual counseling (IC), antidepressant medication (MED), or support groups (SG). Participants were recruited from a surgical oncology office and asked to complete the survey as they waited for their appointment. Preference was compared using Wilcoxon Signed Ranks tests. More than 50% ranked IC as first choice of treatment. Preference for IC was significantly higher than preference for MED and SG. Preference between MED and SG did not differ. Survivors prefered counseling for treatment of depression. Cancer centers should be prepared to provide preferred treatment methods, particulary as screening, and therefore management, of psychosocial distress is to be required.
相当多的癌症患者会经历抑郁。本研究调查了对抑郁症的治疗偏好。乳腺癌幸存者(N = 134)完成了一项匿名调查,询问他们对三种抑郁症治疗方法的偏好和兴趣:个体咨询(IC)、抗抑郁药物(MED)或支持小组(SG)。参与者从外科肿瘤办公室招募,并在等待预约时被要求完成调查。使用Wilcoxon符号秩检验比较偏好。超过50%的人将个体咨询列为首选治疗方法。对个体咨询的偏好显著高于对抗抑郁药物和支持小组的偏好。抗抑郁药物和支持小组之间的偏好没有差异。幸存者更喜欢咨询来治疗抑郁症。癌症中心应准备好提供首选的治疗方法,特别是因为需要对心理社会困扰进行筛查,进而进行管理。